| mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.0006 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.0007 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
| mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0009 |